Journal Article Review Epublish 6 citations
PubMed: 39516934 DOI: 10.1186/s12967-024-05824-1
Advancing cancer research through organoid technology.
J Transl Med 22(1):1007
Authors: Guolong Zeng, Yifan Yu, Meiting Wang, Jiaxing Liu, Guangpeng He, Sixuan Yu, Huining Yan, Liang Yang, Hangyu Li, Xueqiang Peng
Affiliations
- Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, 110032, China.
- Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, 110032, China. Shenyang Clinical Medical Research Center for Diagnosis, Treatment and Health Management of Early Digestive Cancer, Shenyang, China.
- Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, 110032, China. Shenyang Clinical Medical Research Center for Diagnosis, Treatment and Health Management of Early Digestive Cancer, Shenyang, China.
- Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, 110032, China. Shenyang Clinical Medical Research Center for Diagnosis, Treatment and Health Management of Early Digestive Cancer, Shenyang, China.
Abstract
The complexity of tumors and the challenges associated with treatment often stem from the limitations of existing models in accurately replicating authentic tumors. Recently, organoid technology has emerged as an innovative platform for tumor research. This bioengineering approach enables researchers to simulate, in vitro, the interactions between tumors and their microenvironment, thereby enhancing the intricate interplay between tumor cells and their surroundings. Organoids also integrate multidimensional data, providing a novel paradigm for understanding tumor development and progression while facilitating precision therapy. Furthermore, advancements in imaging and genetic editing techniques have significantly augmented the potential of organoids in tumor research. This review explores the application of organoid technology for more precise tumor simulations and its specific contributions to cancer research advancements. Additionally, we discuss the challenges and evolving trends in developing comprehensive tumor models utilizing organoid technology.
MeSH
Biomedical Research, Neoplasms, Organoids, Research, Therapeutics
Cited by
- Immunomodulatory Natural Products in Cancer Organoid-Immune Co-Cultures: Bridging the Research Gap for Precision Immunotherapy. Int J Mol Sci, 2025
- Harnessing Organoid Platforms for Nanoparticle Drug Development. Drug Des Devel Ther, 2025
- Ivermectin Strengthens Paclitaxel Effectiveness in High-Grade Serous Carcinoma in 3D Cell Cultures. Pharmaceuticals (Basel), 2025